v3.26.1
Stockholders' Equity
3 Months Ended
Mar. 31, 2026
Stockholders' Equity [Abstract]  
STOCKHOLDERS’ EQUITY

10. STOCKHOLDERS’ EQUITY

 

Sale of Series C Preferred Stock

 

During the three months ended March 31, 2026, the Company sold 1,800 shares of its Series C Convertible Preferred Stock, with a stated value of $1,000 per share, for aggregate net proceeds of $1,547,800.

 

Conversions of Series C Preferred Stock

 

During the three months ended March 31, 2026, holders of the Company’s Series C Convertible Preferred Stock converted 1,711 shares of Series C Preferred Stock into an aggregate of 122,990 shares of common stock in accordance with the terms of the certificate of designations.

 

Exchange of Series A Preferred Stock

 

In February 2026, the Company issued 58,500 shares of common stock in exchange for the surrender of 39,000 shares of Series A Preferred Stock held by its Chief Executive Officer, a related party. The reacquisition of the preferred stock was accounted for as an equity transaction, and no gain or loss was recognized in the condensed consolidated statements of operations. The excess of the fair value of the common shares issued over the carrying amount of the preferred stock surrendered, amounting to $395,967, was recorded as a deemed dividend and is deducted from net loss in computing net loss attributable to common stockholders.

 

Settlement of Notes Payable and Due to Affiliates

 

As described in Note 6, during the three months ended March 31, 2026, the Company issued an aggregate of 147,281 shares of common stock in settlement of notes payable and amounts due to affiliates.

 

Stock-Based Compensation

 

During the three months ended March 31, 2026, the Company recognized stock-based compensation expense of $222,066, consisting of $28,215 related to the vesting of restricted stock units and $193,851 related to the issuance of 18,462 shares of common stock for services. During the three months ended March 31, 2026, 6,328 shares of common stock were issued in connection with the vesting of restricted stock units. During the three months ended March 31, 2025, the Company recognized stock-based compensation expense of $106,298.